Patent | Date |
---|
Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units Grant 10,364,425 - Chtourou , et al. | 2019-07-30 |
Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units Grant 10,344,272 - Chtourou , et al. July 9, 2 | 2019-07-09 |
Monoclonal antibodies with enhanced ADCC function Grant 10,081,683 - Beliard , et al. September 25, 2 | 2018-09-25 |
Use of ADCC-optimized antibodies for treating low-responder patients Grant 9,879,089 - Bourel , et al. January 30, 2 | 2018-01-30 |
Monoclonal Antibodies With Enhanced Adcc Function App 20180002442 - BELIARD; ROLAND ;   et al. | 2018-01-04 |
Method for purifying active GLA-domain coagulation proteins Grant 9,850,477 - Perret , et al. December 26, 2 | 2017-12-26 |
Monoclonal antibodies with enhanced ADCC function Grant 9,718,889 - Beliard , et al. August 1, 2 | 2017-08-01 |
Monoclonal antibodies with enhanced ADCC function Grant 9,718,890 - Beliard , et al. August 1, 2 | 2017-08-01 |
Monoclonal antibodies with enhanced ADCC function Grant 9,708,409 - Beliard , et al. July 18, 2 | 2017-07-18 |
Method for purifying GLA-domain coagulation proteins Grant 9,359,610 - Perret , et al. June 7, 2 | 2016-06-07 |
Method For Purifying Active Gla-domain Coagulation Proteins App 20160138001 - Perret; Gerard ;   et al. | 2016-05-19 |
Novel Medicaments Comprising An Antibody Composition Enriched With Predominant Charge Isoform App 20160046722 - Chevreux; Guillaume ;   et al. | 2016-02-18 |
Method for purifying active GLA-domain coagulation proteins Grant 9,212,365 - Perret , et al. December 15, 2 | 2015-12-15 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20150307624 - Bourel; Dominique ;   et al. | 2015-10-29 |
Monoclonal Antibodies With Enhanced Adcc Function App 20150266972 - BELIARD; Roland ;   et al. | 2015-09-24 |
Use of ADCC-optimized antibodies for treating weak patients Grant 9,109,020 - Bourel , et al. August 18, 2 | 2015-08-18 |
Monoclonal Antibodies With Enhanced Adcc Function App 20150152189 - Beliard; Roland ;   et al. | 2015-06-04 |
Monoclonal Antibodies With Enhanced Adcc Function App 20140162356 - Beliard; Roland ;   et al. | 2014-06-12 |
Recombinant Or Transgenic Factor Vii Composition, Each Factor Vii Molecule Having Two N-glycosylation Sites With Defined Glycan Units App 20140093491 - Chtourou; Abdessatar Sami ;   et al. | 2014-04-03 |
Monoclonal antibodies with enhanced ADCC function Grant 8,685,725 - Beliard , et al. April 1, 2 | 2014-04-01 |
Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20140017243 - Bourel; Dominique ;   et al. | 2014-01-16 |
Use of ADCC-optimized antibodies for treating weak patients Grant 8,501,171 - Bourel , et al. August 6, 2 | 2013-08-06 |
Recombinant Or Transgenic Factor Vii Compound Having A Majority Of Glycan, Biantennary, Bisialylated And Non-fucosylated Forms App 20130189244 - Chtourou; Abdessatar Sami ;   et al. | 2013-07-25 |
Method For Purifying Gla-domain Coagulation Proteins App 20130143302 - Perret; Gerald ;   et al. | 2013-06-06 |
Monoclonal antibodies with enhanced ADCC function Grant 8,409,572 - Beliard , et al. April 2, 2 | 2013-04-02 |
Anti-D monoclonal antibodies Grant 8,357,370 - Beliard , et al. January 22, 2 | 2013-01-22 |
Method For Purifying Active Gla-domain Coagulation Proteins App 20120271039 - Perret; Gerard ;   et al. | 2012-10-25 |
Monoclonal Antibodies With Enhanced Adcc Function App 20120259095 - Beliard; Roland ;   et al. | 2012-10-11 |
Anti-d Monoclonal Antibodies App 20120258096 - Beliard; Roland ;   et al. | 2012-10-11 |
Method for treating infectious disease using monoclonal antibodies Grant 8,178,093 - Beliard , et al. May 15, 2 | 2012-05-15 |
Method for treating cancer using monoclonal antibodies Grant 8,153,124 - Beliard , et al. April 10, 2 | 2012-04-10 |
Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies Grant 8,124,078 - Beliard , et al. February 28, 2 | 2012-02-28 |
Monoclonal Antibodies With Enhanced Adcc Function App 20110223658 - Beliard; Roland ;   et al. | 2011-09-15 |
Modified Human Factor Vii/viia And Pharmaceutical Composition Containing The Same App 20110162094 - Nony; Emmanuel ;   et al. | 2011-06-30 |
Monoclonal antibodies with enhanced ADCC function Grant 7,931,895 - Beliard , et al. April 26, 2 | 2011-04-26 |
Method For Treating Cancer Using Monoclonal Antibodies App 20110059072 - Beliard; Roland ;   et al. | 2011-03-10 |
Method For Treating Infectious Disease Using Monoclonal Antibodies App 20110059073 - BELIARD; ROLAND ;   et al. | 2011-03-10 |
Method For Treating Idiopathic Thrombocytopenic Purpura Using Monoclonal Antibodies App 20110052571 - Beliard; Roland ;   et al. | 2011-03-03 |
Cytokine production-inducing antibody App 20100323368 - de Romeuf; Christophe ;   et al. | 2010-12-23 |
Use of ADCC-Optimized antibodies for treating weak patients App 20100303826 - Bourel; Dominique ;   et al. | 2010-12-02 |
Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors Grant 7,790,399 - Bourel , et al. September 7, 2 | 2010-09-07 |
Use of ADCC-optimized antibodies for treating low-responder patients Grant 7,713,524 - Bourel , et al. May 11, 2 | 2010-05-11 |
Recombinant Or Transgenic Factor Vii Composition, Each Factor Vii Molecule Having Two N-glycosylation Sites With Defined Glycan Units App 20090311239 - Chtourou; Abdessatar Sami ;   et al. | 2009-12-17 |
Method of measuring activation of effector cells Grant 7,595,165 - Romeuf , et al. September 29, 2 | 2009-09-29 |
Recombinant Or Transgenic Factor Vii Compound Having A Majority Of Glycan, Biantennary, Bisialylated And Non-fucosylated Forms App 20090239788 - Chtourou; Abdessatar Sami ;   et al. | 2009-09-24 |
Method for preparing monoclonal antibodies capable of activating effector cells expressing FC.gamma.RIII Grant 7,579,170 - Beliard , et al. August 25, 2 | 2009-08-25 |
Anti-rhesus D monoclonal antibodies Grant 7,541,029 - Beliard , et al. June 2, 2 | 2009-06-02 |
Novel lgG3 Antibodies for Stimulating Phagocytosis App 20070218052 - Romeuf; Christophe De ;   et al. | 2007-09-20 |
Therapeutic products with enhance ability to immunomodulate cell functions App 20070135621 - Bourel; Dominique ;   et al. | 2007-06-14 |
Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity App 20070015239 - Bihoreau; Nicolas ;   et al. | 2007-01-18 |
Anti-Rhesus D monoclonal antibodies App 20070009522 - Beliard; Roland ;   et al. | 2007-01-11 |
Use of adcc-optimized antibodies for treating weak patients App 20060182741 - Bourel; Dominique ;   et al. | 2006-08-17 |